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ABSTRACT
Nanoscience and nanotechnology are undergoing rapid 
expansion owing to the promise of breakthroughs in key 
sectors, such as energy and medicine. As for medicine, 
interaction of nanomaterials with biological membranes 
is a key issue, both for the development of drug and gene 
delivery vectors and for understanding the molecular basis 
of nanoparticle (NP) biological activity. NP-membrane 
interactions are often studied with the aid of molecular 
simulations of model membranes, allowing to overcome 
the limitations in temporal and spatial resolution generally 
encountered by experimental techniques applied to fluid 
membranes. In the present review we summarize the current 
literature on simulations of NP-membrane interactions, 
focusing on small polymeric and ligand-coated NPs. Open 
questions emerging from experiments concern the effect 
of NP size, surface charge, and ligand arrangement on 
NP partitioning into and permeation across membranes. 
While simulations are contributing to significant progress 
in this area, some challenges remain, namely regarding the 
representation of the complexity of biological environments 
and the cooperative behavior of NPs (e.g. aggregation), as 
well as methodological challenges to tackle the intrinsically 
multi-scale nature of nano–bio interactions.
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Introduction
Biological membranes are designed to protect living cells from the environment, 
while still allowing the entrance of nutrients and the exit of waste materials. They 
are made up of one or two monomolecular layers of lipids, proteins (embedded 
or bound to the surface), and carbohydrates (generally covalently linked to lipids 
and proteins) [1]. The lipid component, spanning a few nanometers in thickness 
[2], keeps together the assembly. Biological membranes perform essential cellular 
functions, such as communication between the cell and the outside world, and 
their properties and functioning depend on membrane composition [3–5]. Lipid 
composition typically includes hundreds to thousands of different lipid species 
[5,6], is specific for each organism and for each tissue and organelle within an 
organism, and is tightly regulated by a number of cellular mechanisms [5,7]. 
Negatively charged lipids are abundant in bacterial membranes [8], while the 
plasma membrane of animal cells contains mostly neutral lipids [5]; the differ-
ence in electrostatic charge explains the selective binding of positively charged 
antimicrobial agents to bacterial membranes [9]. Besides electrostatic charge, also 
structural, elastic, and dynamic properties of lipid membranes depend on lipid 
composition, and they affect membrane functioning and interaction with proteins 
[3,10,11]. Not surprisingly, lipid composition is tightly regulated in bacteria and 
higher organisms [5,12].
The interaction with nanosized exogenous materials effectively alters membrane 
composition and properties, including structural, dynamic, and elastic properties, 
and hence it can alter the normal functioning of the membrane. Due to their 
high surface-to-volume ratio, nanosized particles interact strongly with biological 
membranes, which makes them particularly interesting for technological 
applications requiring the delivery of natural or synthetic particles to cells, but 
also potentially dangerous when such delivery is not desired [13,14]. From a 
technological standpoint, the greatest challenge is probably to design NPs able 
to enter cell membranes passively (i.e. without the need for energy-consuming 
mechanism) and directly, avoiding endocytosis-like mechanisms, and without 
membrane disruption [15]. From the toxicology standpoint, understanding the 
molecular mechanisms of cell membrane entrance and/or damage by NPs would 
help designing safer materials, unable to cross cellular barriers [16,17]. In both 
cases, understanding the molecular-level interactions between NPs and biological 
membranes is paramount to make progress. Experiments probing NP-membrane 
interactions are more and more often complemented by molecular simulations, 
allowing to overcome the limitations in temporal and spatial resolution generally 
encountered by experimental techniques applied to fluid membranes [15,18–20]. 
Due to the complexity of biological membranes, simulations often consider rather 
simple models of biological membranes – i.e. membranes consisting of only one or 
a few lipid types, often without any proteins. While this is a strong simplification, 
it is justified in some cases because the main physical properties of biological 
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membranes stem from lipid self-assembly. The literature in this area has grown so 
much over the past decade that it is now very difficult to provide a comprehensive 
review.
In the present manuscript, we focus on simulation studies of the interaction 
between model lipid membranes and a subgroup of nanoparticles, namely polymer 
and ligand-coated nanoparticles. Both types of nanoparticles present organic 
functional groups on their surface, hence they can have similar surface properties 
– which is important in determining their interaction with lipid membranes – 
and can be simulated using the same methodologies (i.e. force fields, etc.) used 
for simulations of biological macromolecules. Such ‘soft’ nanoparticles are very 
common because relatively easy to synthesize and highly versatile. We further 
restrict our scope to small nanoparticles, with size comparable to the thickness of 
a lipid membrane, as they can be simulated using chemical detail, allowing a direct 
correspondence with nanoparticles used in experiments. Two types of small soft 
nanoparticles are most common: those with a metallic nucleus and those without. 
In the following, we will review critically the simulation studies published so far 
on these two categories of nanoparticles, highlighting the links with experimental 
studies. Before going through the current literature, we summarize the most 
important open questions pertaining to NP interaction with lipid membranes.
Soft nanoparticles: open questions
Experiments probing the interaction of NPs with biological membranes or model 
membranes raised a number of questions on the effect of NP size, shape, surface 
charge, and ligand arrangement, as well as the role of rafts (in a biological context) 
and phase separation (in model membranes).
Role of size and shape
Size and shape have a great impact on NP uptake into cells. First of all, size is 
the main factor determining the mechanism of NP entry. Small NPs (<10 nm) 
can in principle translocate across membranes passively and directly, avoiding 
endocytosis-type mechanisms, with important consequences on the efficiency 
of cargo delivery and on toxicity [21–23]. Second, even for particles entering cell 
membranes using the same mechanism, NP size and shape affect the kinetics of 
internalization, as shown, for example, by Chan and co-workers [21,24]. Yet, two 
questions remain open: first, experimental samples generally possess a certain 
degree of polydispersity; second, samples may aggregate after preparation, even 
upon contact with the cell membrane, changing both size and shape. Uncertainties 
in NP size and shape pose difficulties for understanding the general principles 
of nanomaterial–membrane interactions, particularly in a physiological milieu, 
where it is often difficult (if at all possible) to control NP and membrane properties.
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Role of surface charge
Hydrophobic NPs generally aggregate in aqueous solution and form larger nan-
oparticles. Aggregation makes NPs difficult to handle in solution, reduces the 
surface-to-volume ratio, and alters the mechanism of NP entrance into cells, some-
times increasing NP toxicity [25–28]. To avoid aggregation, often NPs are func-
tionalized or coated with charged ligands. The sign of the charge greatly affects the 
way the NP interacts with lipid membranes, which in turn affects the mechanism 
of NP biological activity: positively charged NPs generally interact more strongly 
with membranes (which generally contain at least a small fraction of negatively 
charged lipids and no positively charged lipids), are internalized more efficiently, 
and display higher toxicity compared to negatively charged NPs [16,29,30]. Some 
experimental evidence indicates that different types of positively charged NPs 
cause the formation of transient pores in lipid membranes [29,31–33]. Attraction 
of cationic NPs to lipid membranes may be explained by electrostatic forces (when 
negatively charged lipids are present in the membrane), but the mechanisms of 
translocation and pore formation remain unclear.
Another way to solubilize NPs, reduce non-specific protein adsorption, and 
reduce NP aggregation is coating with non-charged ligands, such as zwitterionic 
ligands [34], polyethylene oxide (PEO or PEG) [35–37], or hydroxyl groups 
[38]. Zwitterionic ligands also promote internalization by passive transport [23]. 
In general, electrically neutral ligands appear to reduce NP interaction with 
membranes and cell internalization, independently of the chemistry of the NP 
core [39]. Similar considerations hold also for purely organic (polymeric) NPs 
[19]. While differences in biological activity due to NP charge have been confirmed 
with different materials, the molecular basis is highly debated.
Role of ligand arrangement
NP internalization appears to depend not only on NP size and electrostatic charge, 
but also on the arrangement of ligands on the NP surface. The first evidence in 
this direction was published by the group of Stellacci in 2008 [40], showing that 
‘striped’ NPs (i.e. NPs in which ligands with different properties are arranged along 
stripes on the NP surface) can enter cell membranes directly, avoiding endocytosis, 
and without damage to the membrane; NPs with the same chemical composition 
in which ligands are distributed randomly on the surface were endocytosed [40]. 
The finding is particularly important, but an explanation of the molecular mech-
anism is still lacking.
Role of rafts and lipid phase
It has been reported that lipid phase state affects the interaction with NPs, and 
also that NPs can affect the phase state of a biological membrane. For example, 
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the presence of lipid rafts (i.e. functional nanoscale domains usually rich in cho-
lesterol) is necessary for raft-mediated endocytosis; Rotello et al. showed that cho-
lesterol-depleting agents reduce NP uptake independently of NP size and surface 
charge [23]. Considering experiments on non-biological membranes, cationic 
dendrimers were shown to induce holes only in fluid phase membranes, not mem-
branes in the gel phase [41]. On the other hand, Granick et al. have shown that 
charged NPs can affect the phase state of lipid membranes, inducing the formation 
of gel phases in fluid membranes or fluidizing previously gelled membranes [42]. 
Mechanisms have been proposed to explain the interplay between NP properties 
and membrane phase, but evidence is rather indirect.
Coated metal nanoparticles: applications and toxicity
Metallic nanoparticles possess a number of unique physical properties making 
them attractive for applications in different areas of technology and medicine, such 
as imaging of biological tissues [43–45] and photothermal therapies [43,46–48]. 
While applications are numerous, concerns about toxicity are also important. In 
terms of biomedical applications, one of the most important goals is to prepare 
NPs that can efficiently enter cell membranes and access the cytosol (and some-
times the cell nucleus) without membrane disruption. Uncoated, ‘naked’ metal 
nanoparticles are often rather toxic and therefore not biocompatible, and tend to 
have short persistence time in living organisms [49]. The most common strategy 
to reduce toxicity and improve persistence consists in coating the nanoparticles 
with organic ligands or polymers [50]. This is currently a subject of great interest, 
but systematic studies using consistent methodology are generally not available, 
so the relationship between chemical composition (both for the metal and the 
organic coating), physical properties (i.e. particle size, shape, etc.), and toxicity 
remains unclear. In particular, it is unclear what properties determine the inter-
action of nanoparticles with cell membranes. This lack of understanding is ham-
pering progress in the design and development of more effective nanoparticles 
for biomedical applications.
Coated gold nanoparticles: computational studies
The most widely used ligand-coated metallic NPs, both in experimental and sim-
ulation studies, consist of a gold (Au) core. While also several other metal NPs are 
commonly studied experimentally, we deem the current computational literature 
still immature; therefore we will restrict our report to ligand-coated gold NPs.
Gold is generally considered inert with respect to living organisms, and therefore 
nontoxic, at least in bulk form [49]. Also, Au NPs are easy to functionalize in 
different ways (Figure 1), they can be prepared in a range of sizes, their optical 
properties can easily be tuned, and they can efficiently convert light into heat [49]. 
Stable coating can be provided via reaction with thiols, forming Au-S covalent 
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bonds and yielding monodisperse NPs covered with a single layer of organic 
ligands (often referred to as monolayer-protected Au NPs) with different surface 
properties [49].
Simulations of metals with classical molecular mechanics methods generally 
require the use of specialized force fields, typically including multi-body 
interactions [51]. Yet, in monolayer-protected NPs, the organic ligands shield 
the metal core from direct interaction with the environment. In this case, it is 
common practice to ignore the peculiar nature of the metal force field, and use 
simple pairwise potentials, common for biological macromolecules [52]. Both 
atomistic and coarse-grained (CG) force fields have been used in modeling ligand-
coated metal NPs, depending on the particular question at hand.
A number of experimental and simulation studies focused on charged Au NPs, 
in which the organic ligand terminates with positively charged (e.g. amino) or 
negatively charged (e.g. carboxylate) groups. In this case, electrostatics plays an 
important role in driving the interaction between charged NPs and membranes. 
Considering the limitations in current CG models [53], atomistic models should 
be preferred, in principle, for the study of charged NPs. Akola and Vattulainen 
used all-atom simulations to investigate the initial stages of Au NP interaction 
with asymmetric lipid membranes as a function of NP charge [54,55]. They 
showed that cationic NPs bind spontaneously to both negatively charged and 
neutral (zwitterionic) lipid membranes, but binding to neutral membranes 
requires overcoming a 12 kJ/mol free energy barrier. Anionic NPs, instead, only 
bind to neutral membranes. In all cases, only the initial steps of NP-membrane 
interactions could be probed, due to limitations of atomistic simulations in terms 
of time scale. Such limitations can be overcome by the use of CG models, at the 
cost of lower detail and lower accuracy.
Alexander-Katz et al. used the MARTINI CG model [56,57] to simulate the 
entrance of cationic gold NPs (alkanethiol-protected Au NP with ammonium 
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Figure 1. Gold nanoparticles with different functional groups. On the left, atomistic structure of 
the Au-s core of a Au144sR60 nanoparticle (R not shown), as predicted by hakkinen et al.[35]. On the 
right, examples of ligands commonly used in experimental and simulation studies. Reproduced 
with permission from [20].
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terminal groups) following membrane poration by a transmembrane potential 
[31]. A change in the electric field across the membrane could, in principle, be 
generated by the accumulation of charged NPs on the membrane surface. We 
notice, though, that the transmembrane potential used to porate the membrane 
was large (1.5 V), and it is not clear if realistic concentrations of Au NPs could 
generate a transmembrane potential large enough to porate a lipid membrane. 
The same authors also used a thermodynamic approach to describe the entry of 
negatively charged Au NP into membranes [58] (alkanethiol-protected Au NPs, 
with or without sulfonate terminal groups), in which the free energy cost of NP 
translocation is represented as the sum of hydrophobic, hydrophilic, electrostatic, 
bilayer deformation, and ligand entropy contributions:
In the equation above, some of the contributions were calculated based on atom-
istic models, with the membrane and solvent treated implicitly. The main con-
clusions obtained with such approach were: (a) the most stable states present a 
‘snorkeling’ conformation of the NP, i.e. the charged termini of the ligands ‘snorkel’ 
to stably interact with the lipid head groups while the NP core is embedded at the 
center of the membrane; (b) the free energy of transfer depends strongly on NP 
size and on the nature of the ligands, with hydrophobic ligands (alkanethiols with-
out sulfonate groups) favoring membrane embedding [58]. This thermodynamic 
view has three main limitations: first, it relies on several assumptions regarding 
interaction and deformation energies, and therefore it remains mostly qualitative; 
second, it does not clarify the path for NP entrance into a membrane; third, it 
disregards the possibility of NP aggregation, both in the membrane and in the 
aqueous milieu (while aggregation can significantly affect the thermodynamics 
of NP translocation).
Investigating the path for NP insertion into a membrane, Alexander-Katz used 
all-atom simulations of lipid ribbons (i.e. stripes of lipid bilayers with highly 
curved edges, as found also in toroidal pores) to show that the critical step in 
the process is the formation of a contact between hydrophobic ligands and 
hydrophobic lipid chain – a statistically rare event requiring lipid chain protrusion 
(i.e. transient exposure of a hydrophobic lipid chain to the head group region) 
[59]. This finding was confirmed by simulations of spontaneous NP insertion into 
non-curved, defect-free bilayer membranes, upon generation of a hydrophobic 
NP-lipid contact by pulling a lipid acyl chain towards the NP [60].
Rossi and co-workers used CG simulations to explore the energetics of 
generating a snorkeling conformation for a single anionic alkanethiol-protected 
NP in a membrane [61] (Figure 2). They confirmed that NP translocation into 
membranes is a three-step process: (1) NP adhesion to the membrane, driven by 
electrostatic interactions; (2) formation of a hydrophobic contact between NP 
and lipids; (3) translocation towards the center of the membrane as NP ligands 
ΔGtot = ΔGphobic + ΔGphilic + ΔGelec + ΔGthick + TΔSlig
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flip-flop to the opposite membrane leaflet. We notice that only the first of the 
three processes is fast, while the second and third involve rare events, difficult to 
sample even with CG simulations; yet, these can be sampled in simulations only 
using appropriate biasing techniques. The works of Alexander-Katz [60] and Rossi 
[61] represent a first step in this direction, but more work is required to fully 
characterize the energetics of NP translocation.
One of the most intriguing questions on Au NP insertion into membranes 
regards the effect of ligand arrangement, and particularly the difference between 
a random distribution and a distribution with stripes. While experiments 
indicate that striped Au NPs permeate more easily [40], calculations using the 
thermodynamic model of Alexander-Katz show no significant difference in the 
free energy of transfer for different ligand arrangements [58]. Angelikopoulos 
and co-workers used a CG approach to the same problem, calculating the free 
energy of transfer for negatively charged Au NPs of 6 nm in diameter modeled as 
rigid spheres [62]. Calculations relied on the MARTINI CG model [56,57], and 
the presence of two types of ligands was accounted for using different particle 
types (anionic and hydrophobic) on the spherical surface. NPs with ligands 
arranged randomly presented hydrophobic patches (although not stripes) on the 
NP surface, which interact favorably with lipids, slowing down NP permeation. 
The main limitation of this work lies in the NP model itself, which lacks flexibility 
in the arrangement of the ligands, and therefore is difficult to compare with 
experiments on soft, monolayer-protected NP. On the other hand, free energy 
calculations on NPs with flexible ligands require very large sampling, as indicated 
by several authors [60,61,63]. To overcome this problem, Gao and co-workers 
used DPD simulations [64], with a model [65] featuring a level of detail and 
chemical specificity comparable to the MARTINI model [56,57]. They found that 
striped NPs present the lowest free energy barrier for crossing the membrane 
Figure 2. Translocation of a gold nP into a lipid membrane. (a) Adsorption; (b–c) contact between 
lipid chain and nP; (d) partial embedding; (e) nP ligands bind to opposite leaflet. Reproduced 
with permission from [61].
284  G. ROssI ANd L. MONTICELLI
due to restrictions in their rotational degrees of freedom [66]. Yet, the CG nature 
of the model raises questions on the possibility to interpret quantitatively the 
experimental data [40].
Polymeric nanoparticles
As in the case of ligand-coated NPs, polymeric NPs also present organic moieties 
on the surface – e.g. hydrocarbon moieties with hydroxyl, carboxyl, amino, or 
amide functional groups; hence their surface properties can be rather similar to 
the surface properties of ligand-coated metallic NPs. Surface properties are an 
important determinant of NP interaction with both biological membranes (lung 
membranes and cell membranes) and model lipid membranes.
Polymeric nanoparticles are interesting in many areas of medicine as drug 
delivery vectors thanks to increased efficacy of the drug, lesser side effects, and 
the possibility of controlled release [67,68]. Several experimental studies have 
been published on the interaction between polymers and lipid membranes (see 
Refs. [69,70] for recent reviews), while simulation studies are fewer and more 
recent, largely due to the limitations of length and time scale in molecular 
simulations [19]. Here, we review modeling studies on the interaction between 
lipid membranes and different classes of polymers: dendrimers, linear-charged 
polymers, polyethylene oxide (PEO) and its derivatives, and industrial polymers.
Dendrimers
Dendrimers are star-shaped polymers, with a central core linked to a large num-
ber of arms. Each arm contains a branching point, and the number of branching 
points is often referred to as a ‘generation’ (G1, G2, G3, etc.). Branching allows 
a very precise control of the molecular weight [71], and allows fine control of 
electrostatic properties – which, in turn, makes dendrimers good candidates for 
biological applications [72]. Simulations of dendrimers have been covered by 
other recent reviews [73], while here we focus on one more precise aspect: the 
interaction with membranes.
The most popular dendrimers for biological applications are polyamidoamines 
(PAMAM) [32,33,74–78]. It is known from experiments that PAMAM dendrimers 
can penetrate directly lipid membranes [74] and, if charged, they can also damage 
the membrane via pore formation [32]. The interaction with membranes depends 
essentially on three factors: electrostatic interactions (between the dendrimer 
termini and lipid head groups), hydrophobic interaction (between the dendrimer 
core and the lipid tails [76]), and size of the dendrimer.
Early simulations of PAMAM dendrimers in the presence of lipid bilayers 
were performed at the atomistic level [71] and showed that charged dendrimers 
adsorbed onto lipids more favorably than neutral ones. Besides electrostatic 
interactions, also hydrophobic interactions play an important role in dendrimer 
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binding [77]. Limitations in sampling were significant in atomistic simulations, 
since membrane permeation and even membrane equilibration after perturbation 
by inclusions take place on time scales difficult to access until a decade ago. To 
overcome these limitations, Lee and Larson used a CG approach [79–83] based on 
the MARTINI force field [56,57]. Their models reproduced structural properties 
of the dendrimer (e.g. radius of gyration) in an aqueous environment [79] and 
were used to investigate further the charge-dependence of the dendrimer-
lipid interaction. The CG simulations showed that decreasing the charge on 
the dendrimer (by acetylation) progressively reduces the interaction with the 
membrane, so that neutral G3 and G5 dendrimers do not insert in the bilayer, 
while charged equivalents do – a finding later confirmed by NMR experiments 
[76]. Pore formation was observed for large charged dendrimers only, such as G5 
and G7, particularly upon clustering of dendrimers on the bilayer surface [80]. The 
simulation results are consistent with the trends observed experimentally [32]. The 
same authors also investigated the effect of dendrimer PEGylation (i.e. attaching 
polyethylene glycol – PEG – to the dendrimer surface) on their interaction with 
membranes [84]. It is known from experiments that PEGylation is more effective 
than acetylation at reducing nonspecific binding of dendrimers to membranes, 
making PAMAM dendrimers more biocompatible. Simulations confirmed that 
PEGylation reduces pore formation by screening dendrimer charges, preventing 
direct interaction with lipid head groups and with other dendrimers, hindering 
aggregation [84].
Linear polyelectrolites
Polyelectrolytes have applications as drug vectors [85], sensors [86,87], transfect-
ants [88], and biocidal agents [89]. Polycations can form stable complexes with 
nucleic acids (also known as polyplexes) that can be internalized via endocytosis 
[90]. In most cases, the mechanism of interaction between polyelectrolytes and 
lipid membranes is not well understood.
Polyethylenimine (PEI) is one of the most studied polycations, and an effective 
transfectant [90]. Its protonation state is controlled simply by pH, and the 
protonated form (low pH) is known to be cytotoxic [91]. Choudhury et al. studied 
the interaction of linear PEI with zwitterionic (POPC) membranes using atomistic 
MD simulations [92]. In simulations, both the protonated form (extended) and 
the unprotonated form (compact) interacted stably with the membrane surface, 
without affecting membrane structural properties. Despite the short time scale, 
the simulations also indicated that protonated PEI can penetrate the bilayer core, 
locally reduce membrane thickness, and promote pore formation, in agreement 
with experiments [91].
Since bacterial membranes are negatively charged, electrostatic interactions 
play a major role in the bactericidal action of polycations. Hill et al. performed 
atomistic MD simulations of polyelectrolyte oligomers and a model bacterial 
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membrane consisting of both zwitterionic (DOPE) and negatively charged (DOPG) 
phospholipids [93]. Simulations showed that individual cationic oligomers can 
bind the lipid bilayer surface, driven by the electrostatic interactions with the 
lipid phosphate groups. Occasionally an oligomer inserted more deeply in the 
membrane, as observed for PEI [92], without destabilizing membrane structure. 
Simultaneous interaction of two oligomers, instead, led to the formation water 
pores.
In the case of zwitterionic membranes, it is not entirely clear what drives 
the interaction between lipid membranes and polyelectrolytes. Kepczynski 
et al. studied the interaction of POPC membranes with a strong polycation, 
poly(allyl-N,N-dimethyl-N-hexylammonium chloride) (P3) using simulations 
and experiments [94]. P3 decamers caused significant perturbation of membrane 
structure and pore formation. Pore formation was confirmed experimentally, as 
the presence of P3 caused an increase in calcein release from the POPC liposomes. 
As already observed for dendrimers, the interaction of polymer hydrophobic 
side chains with lipid acyl chains appeared to play an important role in polymer 
partitioning within the membrane and subsequent membrane perturbation.
Polyethylene oxide and poloxamers
PEO, also known as PEG, is a chemically inert, water-soluble polymer. Considered 
largely biocompatible, PEO has found industrial applications in drug delivery: 
PEO-coated (PEGylated) liposomes (in which PEO is covalently linked to the 
lipids) are significantly more stable towards leakage than their non-PEGylated 
counterparts, and persist intact in living organisms for longer times – hence the 
nickname ‘stealth liposomes’ [95–97]. Since the interaction of the polymer with the 
lipids is determined by grafting, we will not review here the large body of literature 
on the properties of stealth liposomes. We will focus instead on the interaction of 
lipid membranes with ‘free’ PEO chains (i.e. not covalently linked to lipids). The 
amount of simulation studies on PEG and PEG-containing copolymers available 
in the literature is vast and the present review can only be largely incomplete. We 
will focus particularly on CG simulations, since they can explore time and length 
scales relevant for the interaction with membranes.
The group of Klein has been one of the pioneers in modeling PEG and PEG-
polyethylene surfactants [98] (often referred to as CiEj, where C indicates a CH2–
CH2 unit from ethylene, E indicates the ether group O–CH2–CH2 from PEO, and 
the subscripts indicate the number of repeating units). In CiEj surfactants, the 
length of the hydrophobic and hydrophilic moieties determines the topology of 
the self-assembled aggregate (see Ref. [99] and references therein). Simulations 
showed that, in the presence of a lipid bilayer, the hydrophobic moiety of CiEj 
molecules partitions into the membrane core, while the hydrophilic moiety 
(i.e. PEG) remains in the interface region [100], as expected simply based on 
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polarity. The simulations did not show significant membrane deformations or 
destabilization – possibly due to the relatively short length and time scales.
While other models of PEG [99,101] and CiEj surfactants [99] have been 
developed, the study by Klein remains the only one in the literature, to the best 
of our knowledge, describing the interaction of CiEj with lipid membranes on 
relatively large scales. Another type of PEG derivative, poloxamers, have received 
much more attention. Poloxamers are triblock copolymers (type ABA) with PEG 
as the terminal blocks and polypropylene oxide (PPO) as the central block. They 
are also known as Pluronics and Synperonics and are commercially available 
[102]. Poloxamers are amphiphiles, since PEO is more polar than PPO, and they 
can self-assemble in water to form micelles or other self-assembled structures, 
depending on the length of the PEO and PPO chains [103]. A major application of 
poloxamers is in drug delivery (hydrophobic drugs can be embedded in poloxamer 
micelles) [102], although high doses of the polymer can be toxic. In particular, 
poloxamers with higher affinity for biological membranes are also more hemolytic 
and more cytotoxic [104]. Due to the medical interest of the polymer, studies 
on the relationship among composition, biological activity, and interaction with 
membranes have been numerous [102].
Atomistic simulations by Nawaz et al. [105], reaching time scales of hundreds 
of nanoseconds, showed for different types of poloxamers significant alterations 
of lipid structure and dynamics, particularly for copolymers with shorter PEO 
blocks. No pore formation could be observed, probably because pore formation 
is a cooperative process requiring the interaction with multiple polymer chains 
over time scales longer than those typically accessible with atomistic descriptions.
Roccatano and co-workers studied the interaction of poloxamers with lipid 
membranes using a CG approach [106], focusing on the relationship between 
copolymer composition and cell membrane binding. They developed CG models 
(compatible with the MARTINI force field [56,57]) for three different Pluronics 
with different hydrophilic–hydrophobic balance and different length. Simulations 
involved either individual chains or few copies of poloxamer chains – a situation 
relevant at polymer concentrations below the critical micelle concentration. 
Shorter chains inserted only partially in the lipid bilayer, while longer chains were 
able to cross the membrane entirely, reducing membrane thickness and increasing 
the area per lipid, consistent with experiments [107].
Milano and co-workers took an original approach for the description of 
poloxamers interacting with membranes, developing a CG model based on a 
self-consistent field model [108]. In this model, the calculation of pairwise 
interactions is replaced with the calculation of forces between individual particles 
and an external field – which allows for a significant speed-up of the calculation. 
Simulations with this model showed self-assembly of polymer chains to form 
stable micelles in the absence of the lipid membrane, while, in the presence of a 
lipid bilayer, individual polymer chains were released from the micelle and entered 
the bilayer, until the micelle dissolved. Incorporation of hydrophobic drugs into 
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the polymer micelles stabilized the micelle, while polar drugs (quickly released 
from the micelles) had substantially no effect on micelle stability [108].
Industrial plastics
Industrial plastics (e.g. polyethylene, polypropylene, polystyrene (PS), etc.) are 
produced at a pace of 280 million tons per year and steadily increasing [109]. 
The vast majority of the production is in bulk form, but nanoparticles are also 
commercially available, with size down for 20 nm – significantly larger than the 
thickness of a biological membrane. However, most likely smaller nanoparticles 
are generated by physical and chemical degradation, taking place after disposal 
over time scales between tens and hundreds of years [110]. Micrometer-sized par-
ticles have been observed for a long time in all sorts of marine animals [111–113], 
and it is difficult to imagine any reasons why plastic degradation would stop at 
the micrometer level.
The permeation of nanoplastics through cell membranes and their effect on the 
properties of cell membranes have been recently studied by experiments [114–
116] and simulations [117,118]. Notman and co-workers studied the interaction 
of cross-linked PS nanoparticles (between 1.3 and 3.7 nm in radius) with model 
membranes [117] (Figure 3). They used the MARTINI force field [56,57] and the 
model of PS developed by Rossi et al. [119], and characterized the permeation 
kinetics and thermodynamics. Results showed that, for smaller nanoparticles 
(up to 2.8 nm in radius) the free energy gain in the system upon insertion of the 
nanoparticle in the membrane grows approximately linearly with the area of the 
nanoparticle [117]. Monticelli and co-workers also simulated the interaction of 
PS nanoparticles with membranes using the MARTINI force field [56,57,119], 
considering NPs with size below 8 nm in diameter, but without assuming cross-
linking within the particles [118]. They observed spontaneous entry of PS NPs 
into lipid membranes, and analyzed the effects of the polymer on the properties 
of lipid membranes as well as the effect of the membrane on the polymer 
(Figure 3). In the absence of cross-linking, polymer particles (which are solid 
in water) become substantially liquid upon transfer into the lipid environment 
– a remarkable result not completely unexpected, since the membrane interior 
resembles an alkane environment, and alkanes are reasonably good solvents for 
PS (cyclohexane is a theta-solvent at 307 K [120]). Dissolved as individual chains, 
polymers cause major perturbations in all membrane properties: area per lipid, 
lipid and protein diffusion, and elastic moduli. PS chains also have a striking effect 
on membrane phase behavior – potentially relevant for biological membranes, 
where cholesterol-rich domains play an important role in many physiological 
functions [121,122]. A ternary lipid mixture (with saturated lipids, unsaturated 
lipids, and cholesterol), displaying a temperature-dependent phase separation 
between a liquid-ordered (Lo) phase and liquid-disordered (Ld) phase, was used 
to mimic the phase behavior of biological membranes. PS chains partitioned 
AdVANCEs IN PhysICs: X  289
selectively to Ld phases and significantly stabilized Ld–Lo phase separation [118]. 
Based on a comparison among simulations with other molecules affecting phase 
separation, these authors proposed that the mechanism of stabilization depends 
on the exclusion of cholesterol from the Ld phase [123]. Since the driving forces 
for domain formation in biological membranes are similar, they hypothesized that 
similar effects may be operating also in cell membranes – a prediction amenable 
to experimental verification but not tested to date.
Perspectives
Considering the rapid pace of the progress in nanomaterials and nanotechnology, 
as well as the technological and economic relevance of their applications, it is safe 
to predict that the study of NP interaction with biological materials will continue 
growing in the decades to come. The role of simulations in the design of new 
materials has become more and more prominent during the past 10 years, and 
we expect it to grow also in the area of biomedicine. In the following, we list the 
Figure 3. Polystyrene nPs (PsnP) in membranes. Left panel: snapshots (side view) from simulations 
of cross-linked PsnPs (in blue) at different distances from the center of a lipid membrane (head 
groups in yellow and red, acyl chains in gray). Reproduced with permission from [117]. Right 
panel: snapshots (top view) from simulations of non cross-linked PsnPs (purple) in a lipid 
membrane (cyan), after 5  μs of simulation (top panel) and after 10  μs of the same simulation 
(bottom panel); if not cross-linked, Ps chains melt in the membrane at room temperature. 
Reprinted with permission from [118], copyright (2014) American chemical society.
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main challenges and open questions the simulation community will have to face, 
in our opinion, in order to make more significant contributions to burgeoning 
field of bionanotechnology.
Scientific challenges
Complexity of biological systems
Biological systems generally present a very high degree of complexity – for 
instance, biological membranes typically contain hundreds or thousands of differ-
ent lipid and protein species, asymmetrically distributed between the leaflets, and 
laterally organized in dynamic nanoscale domains [5]. Yet, simulations typically 
deal with extremely simplified models – for example, biological membranes are 
often still modeled using one or a few lipid types, with no proteins, no asymme-
try, and no lateral heterogeneity. The vast majority of the simulations studies on 
NP-membrane interactions reviewed here describe single component lipid mem-
branes. Sometimes the simplification is well justified, as one wishes to dissect the 
different contributions to a certain phenomenon; in other cases, using more com-
plex model systems would add to the relevance of nano-bio interactions. Progress 
in simulating membrane complexity has recently been reported [124–128], paving 
the way to more realistic simulations of NP-biomembrane interactions.
Complexity of NP behavior in realistic environments
In experimental conditions, NPs can aggregate reversibly or irreversibly depend-
ing on environmental factors, sometimes on length and time scales beyond those 
accessible by standard atomistic or CG simulation techniques. Aggregation can 
stabilize the NP in a certain environment compared to another one, altering and 
even reversing the thermodynamic balance of NP distribution (e.g. partitioning 
within a membrane can become unfavorable for large aggregates, see [129]), and 
it can change the mechanism of interaction with membranes (e.g. passive trans-
port vs. endocytosis) and the extent of membrane perturbation. These issues 
have been touched upon by few investigators [130–134], but remain difficult to 
solve as aggregation–disaggregation equilibria are concurrent with NP-membrane 
interactions and they are established on long time scales, difficult to access with 
chemically detailed simulation models. Another factor contributing to the com-
plexity of NP behavior is the occurrence of chemical modifications to the NP, e.g. 
oxidation and degradation. This is often relevant in experimental conditions, but 
has not been considered so far.
Methodological challenges
Time and length scales
A number of very relevant scientific questions on NP interactions with membranes 
require simulations on length and time scales beyond the reach of chemically 
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detailed models. For example, calculations on receptor-mediated NP endocytosis 
have been possible only through the use of highly theoretical models, based on 
assumptions regarding the energy cost of membrane deformation, the energy gain 
upon ligand-receptor binding, etc. [135–141]. The gap between theoretical models 
and experiments on actual NPs can be filled via the use of multi-scale approaches, 
in which detailed simulations provide the input for simulations with coarser mod-
els. Similar considerations are valid for calculations on the thermodynamics of 
partitioning of NPs in membranes, which are challenging due to difficulties in 
sampling rare events. The latter may also benefit from the use of enhanced sam-
pling algorithms [142–144], as recently shown by Rossi and co-workers [145].
Accuracy
Accuracy is an unavoidable concern in all molecular simulations, and particularly 
for simulations of lipid membranes, for which efforts towards the development of 
accurate force fields have been very fragmented. Detailed structural information is 
only available on few lipid types, and no consensus exists on the target properties 
to consider in the parameterization of new force fields. Progress in the quality of 
lipid force fields would certainly increase the reliability and credibility of studies 
on NP-membrane interactions.
A political challenge
Most of the progress in nanomaterials is substantially driven by economic factors, 
pushing towards the development of new technologies to increase the added value 
of industrial manufacturing and (possibly) societal benefits. In this context, fun-
damental science issues receive less attention. With reference to NP-membrane 
interactions, we notice that most simulation studies attempt to make progress on 
issues relevant for new technologies, while few attempts to understand the molec-
ular basis of biological activity or the mechanisms of toxicity of NPs. Devoting 
resources to such fundamental science questions is a political challenge for fund-
ing bodies and the entire scientific community.
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